-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Maintains Buy on LifeStance Health Gr, Raises Price Target to $16

Benzinga·11/06/2026 19:27:06
Listen to the news
Canaccord Genuity analyst Richard Close maintains LifeStance Health Gr (NASDAQ:LFST) with a Buy and raises the price target from $15 to $16.